Over the past day, 22,589 new cases of coronavirus have been detected in Russia, 20,096 people have fully recovered, and 790 patients have died from complications that developed against the background of COVID-19 and concomitant diseases.

Since the beginning of the pandemic, the diagnosis was confirmed in 6 356 784 people in the country, 5 679 842 of them recovered, 161 715 died.

According to Rospotrebnadzor, over the entire period, more than 166.9 million laboratory tests for the SARS-CoV-2 coronavirus were carried out, including 389 thousand in the last day.

More than 1.26 million people remain under medical supervision.

According to the chief sanitary doctor of the Russian Federation Anna Popova, the situation with the spread of COVID-19 in the country "remains quite tense."

“At the same time, we see a decrease in the weekly rate of increase in the number of cases, and this indicates an emerging trend towards stabilization of the epidemic process,” the newspaper Komsomolskaya Pravda quotes her.

Popova said that now the main task of the authorities is to ensure maximum coverage of the population with vaccinations.

The head of Rospotrebnadzor stated that the vaccination process is much more active than a month and a half ago.

According to her, an analysis of the data collected during the vaccination campaign shows that the effectiveness of all domestic vaccines is approximately the same, so Russians can choose any of them.

Popova said that of the total number of those who received at least one dose of the drug, no more than 2.5% fall ill, and of those who received two doses, about 0.7-0.8%.

“Therefore, you can choose any of the vaccines and get yourself vaccinated as soon as possible.

And the most important thing: vaccinated people, even if they get sick, almost never require help in intensive care, ”Popova said.

To date, four vaccines against coronavirus have been registered in Russia: Sputnik V and Sputnik Light, developed by the N.N.

N.F.

Gamalei, "EpiVacCorona" of the state scientific center of virology and biotechnology "Vector", as well as "KoviVak", produced by the Federal Scientific Center for Research and Development of Immunobiological Preparations named after V.I.

M.P.

Chumakov RAS.

According to experts, "Sputnik Light" is more suitable for enhancing the immunity of those who have been ill and those who were vaccinated more than six months ago.

In turn, the Minister of Health of the Russian Federation Mikhail Murashko said that more than 35 million people have already been vaccinated with the first component in Russia.

“In order for the virus to stop spreading and mutating, the transmission chain must be interrupted.

If earlier we could achieve this only by limiting contacts, now there is a way much more effective and reliable - vaccination.

It is important that each person understands the responsibility for their own health and health, and maybe the lives of those around them.

As long as someone is delaying vaccination, the threats are very high, ”he said.

Meanwhile, the Association of Manufacturers and Suppliers of Chemical and Biological Protective Equipment and the Association of Developers and Suppliers of Personal Protective Equipment have asked Prime Minister Mikhail Mishustin to address gaps in the industry regulatory framework that put medical staff at hospitals with coronavirus patients at increased risk of contracting COVID. 19, reports RBC.

In particular, organizations pointed to a simplified product registration procedure, due to which unscrupulous manufacturers mark masks with certain protection classes (FFP2-FFP3) without passing the necessary tests and confirming these protection classes.

Domestic medical institutions purchase just such personal protective equipment.

EU and Sputnik V

Against the background of the ongoing vaccination campaign around the world, the head of the European Commission, Ursula von der Leyen, said that the European Medicines Agency (EMA) still does not have enough convincing data to approve the Russian Sputnik V vaccine.

“It became very quiet around Sputnik V.

The application to the EMA has been submitted for a long time.

However, until now, the manufacturer has not been able to provide sufficient reliable data to prove the safety (of the drug -

RT

), ”she said in an interview with Redaktionsnetzwerk Deutschland.

Von der Leyen added that the situation "raises questions."

  • RIA News

  • © Alexander Galperin

Russian Foreign Minister Sergei Lavrov stated in an interview with Komsomolskaya Pravda that EMA employees are in direct working contact with representatives of the Ministry of Health and the Ministry of Industry and Trade of the Russian Federation.

“According to our information, there are no comments on the vaccine itself and the degree of its effectiveness.

We proceed from the fact that the issue is in the plane of a depoliticized and professional dialogue between specialized structures, ”Lavrov said.

“At the same time, with the wider use of Sputnik V - and today we are talking about almost 70 countries of the world (including eight European ones) - the degree of aggressive rhetoric on the part of individual representatives of the EU and its member states is increasing.

If earlier it was said about the need to "be vigilant", then recently they do not shy away from direct appeals at all not to allow the penetration of "Sputnik V" and foreigners vaccinated by it into the EU, "Lavrov emphasized.

In turn, the Russian permanent representative in Brussels Vladimir Chizhov said that the European Union politicizes the issue of vaccination, as well as everything that "has to do with Russia."

“Instead of the international community to unite and cooperate, we are faced with a kind of vaccine race and outright politicization.

Not from our side, I emphasize, "- quotes his edition" Izvestia ".

The diplomat believes that the international community "missed a historic chance to provide a joint response to the threat", which is equally dangerous for rich and poor countries alike.

Chizhov also did not rule out that the pharmacological lobby could hinder the European recognition of Sputnik V.

Russia applied to the EMA to register Sputnik V in the EU on January 29.

At the end of April, it became known about the completion of the first stage of the examination.

In early June, the Russian Direct Investment Fund said it had not received any criticism from the EMA about the vaccine.

In mid-July, the European regulator stated that the process of evaluating Sputnik V continues.

Meanwhile, on the eve of the European Commission recognized the vaccination certificates of San Marino, where the main drug in the vaccination campaign is "Sputnik V", valid in the EU and in the Schengen countries.

After that, the EC representative explained that the approval of the COVID-certificates of this republic does not mean the approval of the Russian vaccine in the EU.

"The European Commission did not approve any vaccines by making a decision on the equivalence of covid certificates," TASS quotes him.

Plant against COVID-19

Research continues by scientists related to the coronavirus pandemic.

Thus, Australian scientists have found that the plant Nigella sativa (nigella sativa), which grows in the countries of North Africa and Western Asia, can be used in the future to treat coronavirus infection, reports the Medicalxpress portal.

As follows from the material of the journal Clinical and Experimental Pharmacology and Physiology, the active ingredient thymoquinone was found in this plant, which is able to bind to the S-protein of the SARS-CoV-2 coronavirus and prevent the development of infection.

  • Nigella sativa (Nigella sowing)

  • © Wikimedia Commons

Thymoquinone is able to block the cytokine storm that occurs in critically ill patients hospitalized with COVID-19, according to Australian Catholic University (ACU) professor Kanees Fatima Shad.

The publication notes that Nigella sativa is also useful in the treatment of hypertension, high cholesterol and diabetes mellitus, and helps patients with rhinitis and sinusitis, eczema, osteoarthritis and epilepsy in children.

In laboratory studies, the plant effectively destroyed Staphylococcus aureus bacteria and some viruses.